机译:我们在CDDP血药浓度测量下对患有肝转移的胃癌(CT2N1P0H1M0)血液透析(HD)患者进行了CPT-11 + CDDP治疗。 CPT-11在第1天和第14天输注90分钟,而CDDP在第1天输注2小时,每个疗程持续4周。透析日为星期一和星期五,星期五为第一天。在CDDP血药浓度测量的第一个过程中,显示出抗肿瘤作用的游离铂(...
Phase II multi-institutional study of Irinotecan (CPT-11) and Cisplatin (CDDP) on a three-week schedule in patients with advanced non-small cell lung cancer (NSCLC)A phase II multicentre study of a 3-week schedule of irinotecan (CPT-11) and cisplatin providing the highest recommended dose ...
症例は57歳,男性。 胃前庭部小弯の3型胃癌,肝転移,門脈腫瘍栓,大動脈周囲リンパ節転移の診断。 切除不能胃癌のため,まずcisplatin(CDDP)10mg/body/day(dayl～5,8～12)点滴静注,5-fluorouracil(5-FU)500mg/body/day(dayl～14)持続点滴静注を1ク
症例は 76 歳, 男性 . 喫煙 歴 20 本/日× 45 年. 1999 年 左肺 小細胞癌のため CDDP+ VP − 16 に よる 化 学療 法および放射線療法 50Gyを施行 し完 全寛解 を得 た.その後 外来 経過観 察し ていた が, 2 〔 1 〔} 4 年 12 月胸 部GT で右 Si に lcm の 結節 影 を...
But, of note, in the SPIRITS trial, combination therapy with S-1 and cisplatin (CDDP) significantly prolonged OS compared to S-1 monotherapy (P = 0.037; HR, 0.77), suggesting that CPT-11 may not be the best partner to use in combination with S-1 at present....
We report three successful cases with irinotecan (CPT-11 60 mg/m2) + cisplatin (CDDP 30mg/m2) chemotherapy (once in 2 weeks) where S-1 failed to respond to recurrent gastric cancer. Case 1: A total gastrectomy and splenectomy were performed for a cardiac gastric cancer (T3, N2, H0, ...
西安齐岳生物供应药物小分子MTX甲氨蝶呤,紫杉醇PTX,阿霉素DOX,顺铂/CDDP,环丙沙星,甲硝唑偶联白蛋白纳米粒,白蛋白纳米粒包括牛血清白蛋白BSA,人血清白蛋白HSA,卵清白蛋白OVA,小鼠血清白蛋白(MSA),大鼠血清白蛋白(RSA),小麦麦清白蛋白,乳清白蛋白(whey protein),肌白蛋白,豆清白蛋白,蓖麻蛋白,豌豆白蛋白1b ( ...
PURPOSE: CPT-11 (60 mg/m2 on days 1, 8 and 15) in combination with CDDP (80 mg/m2 on day 1) has shown promising antitumor activity for non-small-cell lung cancer (NSCLC), but dose-limiting toxicities (DLT) are leukopenia and diarrhea, with a wide variation among patients. To estima...
Cetuximab (C225) Plus Cisplatin (CDDP) Irinotecan (CPT11) and Thoracic Radiotherapy (TRT) Definitive Treatment for Locally-advanced, Clinically Unresectable Esophageal Cancer: A Southwest Oncology Group (SWOG) Phase II Trial with Molecular Correlates (S0414) ...
2 courses of CPT-11, 60 mg/m2 1, 8, 15, and CDDP 80 mg/m2 day 1. is administered before surgery. Objectives are feasibility, response rate, resection rate, and survival. Patient eligibility is those who have histologically confirmed NSCLC and stage IIIa disease with clinically bulky N2 (...